Understanding Design Controls (to include Adaptive Designs for Clinical Studies) - By AtoZ Compliance
All other Events(no CPF)
|29 Mar 2017 through 29 Mar 2017|
|Medicine & Health > Medical-Speciality|
The design control plan – its contents, functions, uses, life cycle process and the FDA guidance on adaptive design Design Controls are the processes used to design, develop, and manage medical devices that you manufacture. They are mandated by federal regulation however the regulations concerning design controls are vague in terms of the specific process steps required and the approaches that should be taken to achieve compliance should be developed. Knowing how the FDA both views and examines design controls is crucial to achieving compliance throughout the life of the medical devices you manufacture and is one of the most valuable compliance subject areas to explore. Noncompliance in design controls, which are consistently uncovered by the FDA during inspections and examinations, are concerned with the design control process that has been designed and applied and the documentation required to support each design control step. The specific sections of the regulations that apply to design controls include CFR 21 Part 820 Quality System regulation found in Sec. 820.30 and Sec. 820.40. These sections of the regulation are extremely complex and difficult to apply particularly for companies that are new to the medical device field. This webinar will explore how design controls should be designed to meet both the spirit and intent of the regulation and the needs of both the medical device itself and the organization. Also covered briefly will be an explanation of the FDA’s new guidance concerning Adaptive Designs for Medical Device Clinical Studies.
23 February 2017
views | 1 subscribers | Be the first to rate this event
Not-featured (How do I make my event featured?)